|
Aug 5
|
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know
|
|
Aug 5
|
Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors?
|
|
Aug 4
|
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?
|
|
Aug 4
|
Illumina Second Quarter 2025 Earnings: EPS Beats Expectations
|
|
Aug 2
|
Illumina: Will big Pharma come to its rescue? Its CEO thinks so.
|
|
Aug 1
|
Top Technology Executives Recognized at the 2025 Minnesota ORBIE Awards
|
|
Aug 1
|
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims
|
|
Jul 31
|
Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key Metrics
|
|
Jul 31
|
Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates
|
|
Jul 31
|
Illumina (NASDAQ:ILMN) Surprises With Q2 Sales
|
|
Jul 31
|
Illumina: Q2 Earnings Snapshot
|
|
Jul 31
|
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
|
|
Jul 30
|
NuCicer Raises $11.5M to Scale High-Protein Chickpeas and Accelerate Predictive Breeding Platform
|
|
Jul 30
|
3 Genomics Stocks Worth Adding to Your Portfolio in 2025
|
|
Jul 30
|
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics
|
|
Jul 30
|
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
|
|
Jul 30
|
Illumina (ILMN) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Jul 28
|
Illumina (ILMN) Stock Is Up, What You Need To Know
|
|
Jul 28
|
CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
|
|
Jul 28
|
Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
|